Pericarditis treatment: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


==Management of Uncomplicated Pericarditis in the Absence of Significant Pericardial Effusion and Tamponade==
==Management of Uncomplicated Pericarditis in the Absence of Significant Pericardial Effusion and Tamponade==
Patients with uncomplicated acute pericarditis can generally be treated and followed up in an outpatient clinic. The treatment of viral or idiopathic pericarditis is with [[non-steroidal anti-inflammatory drug]]s.  Patients should be observed for side effects since [[NSAID]]s are known to effect the GI mucosa.
Patients with uncomplicated acute pericarditis can generally be treated and followed up in an outpatient clinic. The treatment of viral or idiopathic pericarditis is with [[non-steroidal anti-inflammatory drug]]s.  Patients should be observed for side effects since [[NSAID]]s are known to effect the GI mucosa.  If the underlying cause of pericarditis is something other than a viral cause, the specific etiology should be treated.
 
===Non-Steroidal Anti-inflammatory Drugs (NSAIDs)===
[[NSAIDs]] are the mainstay of therapy for uncomplicated pericarditis (viral or idiopathic pericarditis). The goal of therapy is to reduce pain and inflammation. While symptoms are improved by NSAIDs, the duration of the episode may not be reduced. The preferred NSAID is [[ibuprofen]] which has a large range of doses that can be titrated to the patient's tolerance.<!--
  --><ref name="maisch2">{{cite journal | author=    Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH | title=  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology | journal=  Eur Heart J | year=2004 | pages=587–10 | volume=25 | issue=7 | pmid=15120056 | doi=  10.1016/j.ehj.2004.02.002}}</ref> Depending on the severity of symptoms, the dosing is between 300-800 mg every 6-8 hours for days or weeks as needed. In order to minimize a recurrence of symptoms, a slow tapering of the NSAID dose may be required.  As with all NSAID use, GI prophylaxis should be strongly considered.
 
===Aspirin Therapy===
An alternative therapy is [[aspirin]] 800 mg every 6-8 hours.<!--
  --><ref name="imazio2">{{cite journal | author=  Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R | title=  Day-hospital treatment of acute pericarditis: a management program for outpatient therapy | journal=  J Am Coll Cardiol | year=2004 | pages=1042–6 | volume=43 | issue=6 | pmid=15028364 | doi=  10.1016/j.jacc.2003.09.055}}</ref>
 
===Post MI Pericarditis===
In pericarditis following [[acute myocardial infarction]], NSAIDs other than aspirin should be avoided since they can impair scar formation.
 
===Failure to Respond to a Week of Traditional Therapy==
Failure to respond to NSAIDs within one week (as indicated by persistence of [[fever]], a worsening of symptoms such as [[chest pain]], the development of a new [[pericardial effusion]]), likely indicates that the underlying cause may not be viral or idiopathic in nature.


==Identification of High Risk or Complicated Pericarditis==
==Identification of High Risk or Complicated Pericarditis==
Line 38: Line 52:
* persistent symptomatic pericardial effusion
* persistent symptomatic pericardial effusion


'''''[[NSAIDs]]''''' in ''viral'' or ''idiopathic'' pericarditis. In patients with underlying causes other than viral, the specific etiology should be treated. With idiopathic or viral pericarditis, NSAID is the mainstay treatment. Goal of therapy is to reduce pain and inflammation. The course of the disease may not be affected. The preferred NSAID is [[ibuprofen]] because of rare side effects, better effect on coronary flow, and larger dose range.<!--
 
  --><ref name="maisch2">{{cite journal | author=    Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH | title=  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology | journal=  Eur Heart J | year=2004 | pages=587–10 | volume=25 | issue=7 | pmid=15120056 | doi=  10.1016/j.ehj.2004.02.002}}</ref> Depending on severity, dosing is between 300-800 mg every 6-8 hours for days or weeks as needed. An alternative protocol is [[aspirin]] 800 mg every 6-8 hours.<!--
  --><ref name="imazio2">{{cite journal | author=  Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R | title=  Day-hospital treatment of acute pericarditis: a management program for outpatient therapy | journal=  J Am Coll Cardiol | year=2004 | pages=1042–6 | volume=43 | issue=6 | pmid=15028364 | doi=  10.1016/j.jacc.2003.09.055}}</ref> Dose tapering of NSAIDs may be needed. In pericarditis following acute myocardial infarction, NSAIDs other than aspirin should be avoided since they can impair scar formation. As with all NSAID use, GI protection should be engaged. Failure to respond to NSAIDs within one week (indicated by persistence of fever, worsening of condition, new pericardial effusion, or continuing chest pain) likely indicates that a cause other than viral or idiopathic is in process.


'''''[[Colchicine]]''''' can be used alone or in conjunction with NSAIDs in prevention of recurrent pericarditis and treatment of recurrent pericarditis. For patients with a first episode of acute idiopathic or viral pericarditis, they should be treated with an NSAID plus colchicine 2 mg on first day followed by 1 mg daily [http://circ.ahajournals.org/cgi/content/full/113/12/1622] for three months. <!--
'''''[[Colchicine]]''''' can be used alone or in conjunction with NSAIDs in prevention of recurrent pericarditis and treatment of recurrent pericarditis. For patients with a first episode of acute idiopathic or viral pericarditis, they should be treated with an NSAID plus colchicine 2 mg on first day followed by 1 mg daily [http://circ.ahajournals.org/cgi/content/full/113/12/1622] for three months. <!--

Revision as of 13:20, 25 June 2011

Pericarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

HIV
Post MI
Dressler's syndrome
Post-pericardiotomy
Radiation
Tuberculosis
Uremia
Malignancy

Differentiating Pericarditis from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Pericardial Effusion
Cardiac Tamponade
Constrictive Pericarditis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Pericardiocentesis
Pericardial Window
Pericardial Stripping

Treatment Related Videos

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pericarditis treatment On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pericarditis treatment

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pericarditis treatment

CDC on Pericarditis treatment

Pericarditis treatment in the news

Blogs on Pericarditis treatment

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pericarditis treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

The management of pericarditis depends upon whether the patient has an uncomplicated or a complicated disease course.

Management of Uncomplicated Pericarditis in the Absence of Significant Pericardial Effusion and Tamponade

Patients with uncomplicated acute pericarditis can generally be treated and followed up in an outpatient clinic. The treatment of viral or idiopathic pericarditis is with non-steroidal anti-inflammatory drugs. Patients should be observed for side effects since NSAIDs are known to effect the GI mucosa. If the underlying cause of pericarditis is something other than a viral cause, the specific etiology should be treated.

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

NSAIDs are the mainstay of therapy for uncomplicated pericarditis (viral or idiopathic pericarditis). The goal of therapy is to reduce pain and inflammation. While symptoms are improved by NSAIDs, the duration of the episode may not be reduced. The preferred NSAID is ibuprofen which has a large range of doses that can be titrated to the patient's tolerance.[1] Depending on the severity of symptoms, the dosing is between 300-800 mg every 6-8 hours for days or weeks as needed. In order to minimize a recurrence of symptoms, a slow tapering of the NSAID dose may be required. As with all NSAID use, GI prophylaxis should be strongly considered.

Aspirin Therapy

An alternative therapy is aspirin 800 mg every 6-8 hours.[2]

Post MI Pericarditis

In pericarditis following acute myocardial infarction, NSAIDs other than aspirin should be avoided since they can impair scar formation.

=Failure to Respond to a Week of Traditional Therapy

Failure to respond to NSAIDs within one week (as indicated by persistence of fever, a worsening of symptoms such as chest pain, the development of a new pericardial effusion), likely indicates that the underlying cause may not be viral or idiopathic in nature.

Identification of High Risk or Complicated Pericarditis

Those with high risk factors for developing complications may required admission to an inpatient service for careful observation for hemodynamic compromise. High risk patients include:[2]

  • subacute onset
  • high fever (> 100.4 F) and leukocytosis
  • development of cardiac tamponade
  • large pericardial effusion (echo-free space > 20 mm) resistant to NSAID treatment
  • immunocompromised
  • history of oral anticoagulation therapy
  • acute trauma
  • failure to respond to seven days of NSAID treatment.


Severe cases of pericarditis may require:


Usual Steps in Treatment of Pericarditis

Pericardiocentesis is a procedure whereby the fluid in a pericardial effusion is removed through a needle. It is performed under the following conditions:[1]

  • presence of moderate or severe cardiac tamponade
  • diagnostic purpose for suspected purulent, tuberculosis, or neoplastic pericarditis
  • persistent symptomatic pericardial effusion


Colchicine can be used alone or in conjunction with NSAIDs in prevention of recurrent pericarditis and treatment of recurrent pericarditis. For patients with a first episode of acute idiopathic or viral pericarditis, they should be treated with an NSAID plus colchicine 2 mg on first day followed by 1 mg daily [3] for three months. [3][4][5]

Corticosteroids are usually used in those cases that are clearly refractory to NSAIDs and colchicine and a specific cause has not been found. Systemic corticosteroids are usually reserved for those with autoimmune disease.

References

  1. 1.0 1.1 Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology". Eur Heart J. 25 (7): 587–10. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.
  2. 2.0 2.1 Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R (2004). "Day-hospital treatment of acute pericarditis: a management program for outpatient therapy". J Am Coll Cardiol. 43 (6): 1042–6. doi:10.1016/j.jacc.2003.09.055. PMID 15028364.
  3. Adler Y, Zandman-Goddard G, Ravid M, Avidan B, Zemer D, Ehrenfeld M, Shemesh J, Tomer Y, Shoenfeld Y (1994). "Usefulness of colchicine in preventing recurrences of pericarditis". Am J of Cardiol. 73 (12): 916–7. doi:10.1016/0002-9149(94)90828-1. PMID 8184826.
  4. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R (2005). "Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial". Circulation. 112 (13): 2012–6. doi:10.1161/CIRCULATIONAHA.105.542738. PMID 16186437.
  5. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R (2005). "Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial". Arch Intern Med. 165 (17): 1987–91. doi:10.1001/archinte.165.17.1987. PMID 16186468.

Template:SIB

de:Perikarditis nl:Pericarditis sv:Hjärtsäcksinflammation


Template:WikiDoc Sources